Jordi Gras

Summary

Publications

  1. doi Bedaquiline for the treatment of pulmonary, multidrug-resistant tuberculosis in adults
    J Gras
    Drugs Today (Barc) 49:353-61. 2013
  2. doi Ingenol mebutate: a new option for actinic keratosis treatment
    J Gras
    Barcelona, Spain
    Drugs Today (Barc) 49:15-22. 2013
  3. doi Semuloparin for the prevention of venous thromboembolic events in cancer patients
    J Gras
    Drugs Today (Barc) 48:451-7. 2012
  4. doi Mirabegron for the treatment of overactive bladder
    J Gras
    Drugs Today (Barc) 48:25-32. 2012
  5. doi Icatibant for hereditary angioedema
    Jordi Gras
    Drugs Today (Barc) 45:855-64. 2009
  6. doi Edoxaban for the prevention of thromboembolic events after surgery
    J Gras
    Barcelona, Spain
    Drugs Today (Barc) 47:753-61. 2011

Detail Information

Publications6

  1. doi Bedaquiline for the treatment of pulmonary, multidrug-resistant tuberculosis in adults
    J Gras
    Drugs Today (Barc) 49:353-61. 2013
    ..Bedaquiline was generally safe and well tolerated. At the end of 2012, the U.S. Food and Drug Administration approved bedaquiline (Sirturo®) as part of a combination therapy to treat adults with multidrug-resistant TB. ..
  2. doi Ingenol mebutate: a new option for actinic keratosis treatment
    J Gras
    Barcelona, Spain
    Drugs Today (Barc) 49:15-22. 2013
    ..e., erythema, flaking/scaling and crusting, were transient, and resolved spontaneously without sequelae. Adherence to the therapy can be facilitated by the short duration of the treatment...
  3. doi Semuloparin for the prevention of venous thromboembolic events in cancer patients
    J Gras
    Drugs Today (Barc) 48:451-7. 2012
    ....
  4. doi Mirabegron for the treatment of overactive bladder
    J Gras
    Drugs Today (Barc) 48:25-32. 2012
    ..Mirabegron may be an alternative in patients with OAB who are poor responders to antimuscarinic agents or intolerant of their adverse effects...
  5. doi Icatibant for hereditary angioedema
    Jordi Gras
    Drugs Today (Barc) 45:855-64. 2009
    ..Icatibant is a new, safe and effective treatment for acute attacks of HAE...
  6. doi Edoxaban for the prevention of thromboembolic events after surgery
    J Gras
    Barcelona, Spain
    Drugs Today (Barc) 47:753-61. 2011
    ..Edoxaban is safe and well tolerated, with predictable pharmacokinetics (low intersubject variability and low protein binding), suggesting that coagulation monitoring may not be required...